News & Alerts
-
Jul- 2023 -26 July
Doctor Cleared of Liability in Child’s Necrotizing Pancreatitis Case, Jury Verdict Reveals
In a recent incident that garnered significant attention, a Georgia doctor Dr. Nirav Patel found himself at the center of…
Read More » -
26 July
Inflammatory Bowel Disease (IBD) Symptoms That Are Easy to Miss
Inflammatory Bowel Disease (IBD) has a long and evolving history that dates back to ancient times. Early medical texts from…
Read More » -
25 July
Walgreens Appoints Monica Reed As Vice President of its Health Centers Strategy and Operations
Walgreens has announced the appointment of Monica Reed, PharmD, as the new Vice President of Health Centers Strategy and Operations.…
Read More » -
25 July
Cabometyx Patent Battle Resolved As Exelixis Grants Teva 2031 Generic License in Settlement
In recent years, Exelixis has been involved in a fierce battle to safeguard its flagship cancer drug, Cabometyx, by defending…
Read More » -
25 July
FDA Approves Ycanth Topical Treatment for Molluscum Contagiosum
The U.S. Food and Drug Administration has recently given its approval for the topical solution known as Ycanth (cantharidin) to…
Read More » -
25 July
Counter Misinformation on TikTok: Pediatric Dermatologists’ Charge at SPD Meeting
Experts at the Society for Pediatric Dermatology (SPD) 2023 Annual Meeting, have warned that TikTok, along with several other social…
Read More » -
25 July
Cancer Drug Shortages Threaten Progress Of Vital Clinical Trials
Many agencies involved in cancer research and clinical trials are facing significant challenges due to the shortage of cancer drugs,…
Read More » -
25 July
FDA’s Action Plan to Tackle Pfizer’s Damaged Plant and Drug Shortages
The aftermath of the EF-3 tornado that struck the Pfizer plant in Rocky Mount, N.C., has raised concerns about potential…
Read More » -
24 July
Quinoa: Recipes, Medicinal Benefits, How to Cook it, Side Effects
What is Quinoa? Quinoa (Chenopodium quinoa) is a highly nutritious grain-like crop that has gained popularity worldwide for its numerous…
Read More » -
24 July
ADC Therapeutics Discontinues Zynlonta Trial After 7 Deaths Led to An FDA Partial Hold
ADC Therapeutics, a biotechnology company, has decided to discontinue its Zynlonta trial following a partial clinical hold imposed by the…
Read More »